Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc. appears in FDA public data with 1 recall, 0 510(k) clearances, 13 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1124-2017, Class II) was initiated on August 15, 2017.
Summary
- Total Recalls
- 1
- 510(k) Clearances
- 0
- Inspections
- 13
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1124-2017 | Class II | Ketorolac Tromethamine Injection, USP 30 mg/mL, packaged in 1 mL single-dose vials, Rx only, Amphast | August 15, 2017 |